Prevention of bronchopulmonary dysplasia with vitamin E administration during the acute stages of respiratory distress syndrome.
D000818:Animals; D004311:Double-Blind Method; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control*; D007235:Infant, Premature, Diseases / Q000628:therapy; D008168:Lung / Q000187:drug effects / Q000503:physiopathology; D008171:Lung Diseases / Q000517:prevention & control*; D010100:Oxygen / Q000633:toxicity; D010919:Placebos; D012127:Respiratory Distress Syndrome, Newborn / Q000628:therapy*; D012138:Respiratory Therapy; D014810:Vitamin E / Q000627:therapeutic use*; D014811:Vitamin E Deficiency / Q000503:physiopathology
D010919:Placebos; D014810:Vitamin E; D010100:Oxygen